Thompson Davis & Co., Inc. Repligen Corp Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $128,952 - $206,367	-800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $160,933 - $197,905	650 Added 433.33%	800 $212,000
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $4,680 - $5,897	100 Added 200.0%	150 $8,000
Q2 2018 Aug 03, 2018	BUY	$35.26 - $47.04 $1,763 - $2,352	50 New	50 $2,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.96B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.